Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
CanariaBio Inc.
CanariaBio Inc.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Northwell Health
Zhongshan Hospital Xiamen University
Critical Outcome Technologies Inc.
Shenzhen SiBiono GeneTech Co.,Ltd
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Southampton